126 related articles for article (PubMed ID: 33385755)
1. Functional characterization of a novel SLC40A1 Arg88Ile mutation in a kindred with familial iron overload treated by phlebotomy.
Womack J; Sukumaran A; Li X; Lozovatsky L; Gallagher PG; Seid JE; Finberg KE
Blood Cells Mol Dis; 2021 Mar; 87():102532. PubMed ID: 33385755
[No Abstract] [Full Text] [Related]
2. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man.
Del-Castillo-Rueda A; Moreno-Carralero MI; Alvarez-Sala-Walther LA; Cuadrado-Grande N; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Eur J Haematol; 2011 Mar; 86(3):260-4. PubMed ID: 21175851
[TBL] [Abstract][Full Text] [Related]
3. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A
Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838
[TBL] [Abstract][Full Text] [Related]
4. Gene symbol: SLC40A1. Disease: Primary iron overload.
Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
Hum Genet; 2005 May; 116(6):541. PubMed ID: 15991323
[No Abstract] [Full Text] [Related]
5. Gene symbol: SLC40A1. Disease: primary iron overload.
Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
Hum Genet; 2005 Dec; 118(3-4):547. PubMed ID: 16521305
[No Abstract] [Full Text] [Related]
6. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of hepcidin levels in a patient with G80S-linked ferroportin disease undergoing iron depletion by phlebotomy.
Wolff F; Bailly B; Gulbis B; Cotton F
Clin Chim Acta; 2014 Mar; 430():20-1. PubMed ID: 24370385
[No Abstract] [Full Text] [Related]
8. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
10. SLC40A1-R178G mutation and ferroportin disease.
Speletas M; Onoufriadis E; Kioumi A; Germenis AE
J Hepatol; 2011 Sep; 55(3):730-731. PubMed ID: 21320560
[No Abstract] [Full Text] [Related]
11. [Hereditary iron overload].
Brissot P; Bardou-Jacquet E; Latournerie M; Ropert-Bouchet M; Island ML; Loréal O; Jouanolle AM
Pathol Biol (Paris); 2010 Oct; 58(5):316-23. PubMed ID: 19942367
[TBL] [Abstract][Full Text] [Related]
12. SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting.
Wallace DF
J Hepatol; 2013 Aug; 59(2):396-7. PubMed ID: 23523714
[No Abstract] [Full Text] [Related]
13. Reply to: "SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting".
Speletas M; Kioumi A; Germenis AE
J Hepatol; 2013 Aug; 59(2):397. PubMed ID: 23523713
[No Abstract] [Full Text] [Related]
14. G80S-linked ferroportin disease: the first clinical description in a Greek family.
Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
[No Abstract] [Full Text] [Related]
15. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
De Domenico I; McVey Ward D; Nemeth E; Ganz T; Corradini E; Ferrara F; Musci G; Pietrangelo A; Kaplan J
Haematologica; 2006 Aug; 91(8):1092-5. PubMed ID: 16885049
[TBL] [Abstract][Full Text] [Related]
17. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
18. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
[TBL] [Abstract][Full Text] [Related]
19. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload.
Jouanolle AM; Douabin-Gicquel V; Halimi C; Loréal O; Fergelot P; Delacour T; de Lajarte-Thirouard AS; Turlin B; Le Gall JY; Cadet E; Rochette J; David V; Brissot P
J Hepatol; 2003 Aug; 39(2):286-9. PubMed ID: 12873829
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload.
Camberlein E; Abgueguen E; Fatih N; Canonne-Hergaux F; Leroyer P; Turlin B; Ropert M; Brissot P; Loréal O
Biochim Biophys Acta; 2010 Mar; 1802(3):339-46. PubMed ID: 20045050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
